Black AIDS Institute Applauds FDA Approval Of PrEP

PrEP Pill bottle

PrEP – Antiretroviral Pre-exposure Prophylaxis

The Black AIDS Institute recently announced its support of the FDA’s decision to approve use of the antiretroviral drug Truvada as an option for HIV prevention.

Gilead Sciences, maker of Truvada, based its application on results of two placebo-controlled trials-iPrEx in men who have sex with men and Partners PrEP in HIV-discordant heterosexual African couples.

Celebrate great health! LIKE on Facebook!
[ione_facebook_like_box height=”260″]